Rankings
▼
Calendar
RMD FY 2022 Earnings — ResMed Inc. Revenue & Financial Results | Market Cap Arena
RMD
ResMed Inc.
$36B
FY 2022 Earnings
Healthcare
Medical - Instruments & Supplies
Income Statement
Revenue
$3.6B
+11.9% YoY
Gross Profit
$2.0B
56.6% margin
Operating Income
$1.0B
28.0% margin
Net Income
$779M
21.8% margin
EPS (Diluted)
$5.30
Cash Flow
Operating Cash Flow
$351M
Free Cash Flow
$195M
Stock-Based Comp.
$65M
Balance Sheet
Total Assets
$5.1B
Total Liabilities
$1.7B
Stockholders' Equity
$3.4B
Cash & Equivalents
$274M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$3.6B
$3.2B
+11.9%
Gross Profit
$2.0B
$1.8B
+10.1%
Operating Income
$1.0B
$904M
+10.7%
Net Income
$779M
$475M
+64.3%
← Q4 2021
All Quarters
Q1 2022 →